Related Experiment Video
Updated: Jun 14, 2025
03:30
Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
Published on: October 25, 2024
1.4K
Single Incision Sling Surgery for Female Stress Urinary Incontinence: A Retrospective Cohort Single-Institution Study
Ayman Qatawneh1, Fidaa Thekrallah1, Huda M Alaqqad2
1Department of Gynecology and Obstetrics, School of Medicine, The University of Jordan, Amman 11942, Jordan.
Journal of Clinical Medicine
|August 29, 2024
Summary
The Altis single incision sling (SIS) procedure shows high cure rates for stress urinary incontinence (SUI) in women. However, effectiveness is lower for recurrent SUI cases, indicating a need for further research.
Area of Science:
- Urology
- Gynecology
Background:
- Stress urinary incontinence (SUI) affects 35% of adult women, impacting quality of life.
- Single incision slings (SIS) like Altis® were developed to improve upon traditional slings and reduce complications.
Purpose of the Study:
- Evaluate subjective and objective cure rates of the Altis® SIS for SUI, mixed urinary incontinence (MUI), recurrent SUI, and SUI with prolapse.
- Report complications associated with the Altis® procedure.
Main Methods:
- Retrospective cohort study at Jordan University Hospital.
- 111 women underwent the Altis® SIS procedure between June 2016 and June 2019.
- Chi-square analysis compared cure rates between subgroups.
Main Results:
- Overall subjective and objective cure rates were 81% and 85%, respectively.
- MUI patients had lower subjective cure rates (70%) than SUI patients (86%).
- Recurrent SUI patients showed significantly lower cure rates (56% subjective and objective). Mild pain (2.7%), vaginal tape erosion (2.7%), and re-operation (9%) were reported complications.
Conclusions:
- The Altis® SIS procedure is effective for SUI with a 19-month follow-up.
- Effectiveness is reduced in patients with recurrent SUI compared to primary SUI.
- Further prospective studies with larger sample sizes are needed to confirm efficacy in recurrent SUI cases.
